Comparison of the Diagnostic Accuracy of Neuropsychological Tests in Differentiating Alzheimer's Disease from Mild Cognitive Impairment: Can the Montreal Cognitive Assessment Be Better than the Cambridge Cognitive Examination?

OBJECTIVE: Considering the lack of studies on measures that increase the diagnostic distinction between Alzheimer's disease (AD) and mild cognitive impairment (MCI) and on the role of the Cambridge Cognitive Examination (CAMCOG) in this, our study aims to compare the utility of the CAMCOG, Mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinelli, José Eduardo, Cecato, Juliana Francisca, Bartholomeu, Daniel, Montiel, José Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067730/
https://www.ncbi.nlm.nih.gov/pubmed/24987399
http://dx.doi.org/10.1159/000360279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067730/
https://www.ncbi.nlm.nih.gov/pubmed/24987399
http://dx.doi.org/10.1159/000360279

Ejemplares similares